当前位置: 首页 >> 检索结果
共有 132541 条符合本次的查询结果, 用时 3.4023638 秒

361. Harnessing China's universities for global health.

作者: Dong Roman Xu.;Feng Cheng.;Yingyao Chen.;Yuantao Hao.;Judith Wasserheit.; .
来源: Lancet. 2016年388卷10054期1860-1862页

362. Pursuing excellence in graduate medical education in China.

作者: Yupei Zhao.;Shuyang Zhang.;Wenkai Li.;Lincoln Chen.
来源: Lancet. 2016年388卷10054期1859-1860页

363. Care with ratings for cancer.

作者: The Lancet.
来源: Lancet. 2016年388卷10054期1852页

364. Protecting health in Yemen.

作者: The Lancet.
来源: Lancet. 2016年388卷10054期1852页

365. The best science for achieving Healthy China 2030.

作者: The Lancet.
来源: Lancet. 2016年388卷10054期1851页

366. 2016 Nobel prize in medicine goes to Japanese scientist.

作者: Dara Mohammadi.
来源: Lancet. 2016年388卷10054期1870页

367. The fight against rabies: the Middle East needs to step up its game.

作者: Hossein Bannazadeh Baghi.;Ahad Bazmani.;Mohammad Aghazadeh.
来源: Lancet. 2016年388卷10054期1880页

368. Thoughts on relief for atomic bomb survivors since Obama's visit to Hiroshima.

作者: Shigenobu Nagataki.
来源: Lancet. 2016年388卷10054期1878-1879页

369. Invasive management of acute coronary syndromes.

作者: William S Weintraub.
来源: Lancet. 2016年388卷10054期1856-1857页

370. Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.

作者: Lars Wallentin.;Lars Lindhagen.;Elisabet Ärnström.;Steen Husted.;Magnus Janzon.;Søren Paaske Johnsen.;Frederic Kontny.;Tibor Kempf.;Lars-Åke Levin.;Bertil Lindahl.;Mats Stridsberg.;Elisabeth Ståhle.;Per Venge.;Kai C Wollert.;Eva Swahn.;Bo Lagerqvist.; .
来源: Lancet. 2016年388卷10054期1903-1911页
The FRISC-II trial was the first randomised trial to show a reduction in death or myocardial infarction with an early invasive versus a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome. Here we provide a remaining lifetime perspective on the effects on all cardiovascular events during 15 years' follow-up.

371. Gemcitabine: a game changer in nasopharyngeal carcinoma.

作者: Melvin L K Chua.;Anthony T C Chan.
来源: Lancet. 2016年388卷10054期1853-1854页

372. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.

作者: Li Zhang.;Yan Huang.;Shaodong Hong.;Yunpeng Yang.;Gengsheng Yu.;Jun Jia.;Peijian Peng.;Xuan Wu.;Qing Lin.;Xuping Xi.;Jiewen Peng.;Mingjun Xu.;Dongping Chen.;Xiaojun Lu.;Rensheng Wang.;Xiaolong Cao.;Xiaozhong Chen.;Zhixiong Lin.;Jianping Xiong.;Qin Lin.;Conghua Xie.;Zhihua Li.;Jianji Pan.;Jingao Li.;Shixiu Wu.;Yingni Lian.;Quanlie Yang.;Chong Zhao.
来源: Lancet. 2016年388卷10054期1883-1892页
Outcomes are poor for patients with recurrent or metastatic nasopharyngeal carcinoma and no well established first-line chemotherapy is available for the disease. We compared the efficacy and safety of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

374. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial.

作者: Xian Su.;Zhao-Ting Meng.;Xin-Hai Wu.;Fan Cui.;Hong-Liang Li.;Dong-Xin Wang.;Xi Zhu.;Sai-Nan Zhu.;Mervyn Maze.;Daqing Ma.
来源: Lancet. 2016年388卷10054期1893-1902页
Delirium is a postoperative complication that occurs frequently in patients older than 65 years, and presages adverse outcomes. We investigated whether prophylactic low-dose dexmedetomidine, a highly selective α2 adrenoceptor agonist, could safely decrease the incidence of delirium in elderly patients after non-cardiac surgery.

375. Preventing postoperative delirium: all that glisters is not gold.

作者: Vanessa L Kronzer.;Michael S Avidan.
来源: Lancet. 2016年388卷10054期1854-1856页

376. Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study.

作者: Inge Kroidl.;Elmar Saathoff.;Lucas Maganga.;Williams H Makunde.;Achim Hoerauf.;Christof Geldmacher.;Petra Clowes.;Leonard Maboko.;Michael Hoelscher.
来源: Lancet. 2016年388卷10054期1912-1920页
The past decades have seen an ongoing controversial debate about whether the immune activation induced by helminths has an effect on the susceptibility of individuals to HIV. In view of this, we assessed the effect of lymphatic filariasis, a chronic helminth disease elicited by Wuchereria bancrofti, on HIV incidence in southwest Tanzania.

377. No more neglect of helminths and HIV.

作者: Jennifer A Downs.;Daniel W Fitzgerald.
来源: Lancet. 2016年388卷10054期1857-1859页

378. Doctors in China: improving quality through modernisation of residency education.

作者: Jiming Zhu.;Wenkai Li.;Lincoln Chen.
来源: Lancet. 2016年388卷10054期1922-1929页
There is growing recognition that the ultimate success of China's ambitious health reform (enacted in 2009) and higher education reform (1998) depends on well educated health professionals who have the clinical, ethical, and human competencies necessary for the provision of quality services. In this Review, we describe and analyse graduate education of doctors in China by discussing the country's health workforce and their clinical residency education. China has launched a new system called the 5 + 3 (5 year undergraduate and 3 year residency [standardised residency training]), which aims to set national quality standards. To improve understanding for the Chinese model, we present a comparative perspective with systems from the UK and USA. To succeed, the 5 + 3 model will need to overcome major challenges of accreditation and certification, alternative education pathways, and China's unique degree and credentialing system. We conclude by reviewing the challenges of clinical competencies in China, especially the complementarity of specialist training and general practitioner training, which are essential for the quality and equity of China's health-care system.

379. Uric acid bladder stones in congenital cyanotic heart disease.

作者: Ashish Shah.;Michelle Keir.;Robin Ducas.;Andrew M Crean.
来源: Lancet. 2016年388卷10054期1921页

380. WHO's Director-General candidates: visions and priorities.

作者: Richard Horton.;Udani Samarasekera.
来源: Lancet. 2016年388卷10056期2072-2095页
共有 132541 条符合本次的查询结果, 用时 3.4023638 秒